
FONAR Corporation FONR
$ 18.35
0.05%
Quarterly report 2025-Q4
added 02-13-2026
FONAR Corporation Gross Profit 2011-2026 | FONR
Gross profit is a key indicator of how efficiently a company produces or sells its products. This metric helps assess a business’s ability to generate revenue at the initial stage, before accounting for all other expenses. Regular analysis of gross profit allows companies to respond in a timely manner to changes in cost of goods, pricing strategy, and market conditions.
Calculation formula:Importance for business:
Gross Profit = Revenue – Cost of Goods Sold (COGS)
Revenue — all cash inflows from the sale of goods or services.
Cost of Goods Sold — direct costs related to the production or acquisition of goods:
- Raw materials and supplies
- Wages of production personnel
- Depreciation of equipment
- Transportation and warehousing costs (if directly related to production)
- Assessing core business profitability
If gross profit is declining, it may indicate rising production costs or falling sales. - Financial planning
Gross profit is the basis for calculating other key metrics, such as operating and net profit. - Benchmarking against competitors
Gross profit analysis helps compare the efficiency of different companies within the same industry. - Insights into pricing effectiveness
If gross profit is low, the company may be pricing too low or failing to control costs effectively.
- Increase in raw material and supply costs
- Rising production expenses
- Price reductions due to competition
- Decrease in sales volume
- Currency exchange rate fluctuations (for imports/exports)
Gross profit is an important metric, but it does not provide a complete picture of a company’s financial health, as it does not account for administrative and selling expenses, taxes, debt burden, or depreciation.
Annual Gross Profit FONAR Corporation
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | 42.4 M | 43.2 M | 39.6 M | 40 M | 34.5 M | 30.6 M | 31.3 M | 23 M | 18.2 M | 14.7 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 43.2 M | 14.7 M | 31.7 M |
Gross Profit of other stocks in the Medical devices industry
| Issuer | Gross Profit | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Alphatec Holdings
ATEC
|
532 M | $ 11.9 | -2.06 % | $ 1.79 B | ||
|
Butterfly Network
BFLY
|
48.8 M | $ 4.29 | 2.39 % | $ 908 M | ||
|
GenMark Diagnostics, Inc.
GNMK
|
67.9 M | - | - | $ 1.77 B | ||
|
Axonics Modulation Technologies
AXNX
|
198 M | - | - | $ 3.31 B | ||
|
Aziyo Biologics
AZYO
|
6.6 M | - | 1.37 % | $ 20.5 M | ||
|
Acutus Medical
AFIB
|
-3.14 M | - | -26.83 % | $ 2.62 M | ||
|
Allied Healthcare Products
AHPI
|
443 K | - | 3.58 % | $ 2.21 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
584 K | - | -5.86 % | $ 30.6 M | ||
|
BioSig Technologies
BSGM
|
229 K | - | 37.08 % | $ 85.7 M | ||
|
LivaNova PLC
LIVN
|
940 M | $ 62.99 | -0.4 % | $ 3.44 B | ||
|
Conformis
CFMS
|
23.2 M | - | - | $ 16.4 M | ||
|
LENSAR
LNSR
|
14.1 M | $ 5.72 | -5.85 % | $ 65.9 M | ||
|
Cardiovascular Systems
CSII
|
173 M | - | 0.15 % | $ 844 M | ||
|
IRIDEX Corporation
IRIX
|
21.8 M | $ 1.35 | -0.22 % | $ 21.8 M | ||
|
Apollo Endosurgery
APEN
|
42.4 M | - | - | $ 475 M | ||
|
Medtronic PLC
MDT
|
19.6 B | $ 87.15 | -0.07 % | $ 112 B | ||
|
Avinger
AVGR
|
2 M | - | -20.74 % | $ 369 K | ||
|
CryoLife, Inc.
CRY
|
168 M | - | -4.14 % | $ 702 M | ||
|
AxoGen
AXGN
|
167 M | $ 32.23 | 1.51 % | $ 1.48 B | ||
|
CONMED Corporation
CNMD
|
750 M | $ 36.47 | -0.44 % | $ 1.13 B | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
4.25 K | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
28.7 M | - | 0.03 % | $ 1.58 B | ||
|
Electromed
ELMD
|
50 M | $ 24.44 | -0.2 % | $ 207 M | ||
|
Misonix, Inc.
MSON
|
43.7 M | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
1.99 M | - | - | $ 111 M | ||
|
Intersect ENT, Inc.
XENT
|
50.2 M | - | - | $ 955 M | ||
|
Cytosorbents Corporation
CTSO
|
25.1 M | $ 0.68 | 0.86 % | $ 37 M | ||
|
Aethlon Medical
AEMD
|
1.36 M | $ 2.24 | -2.61 % | $ 3.5 M | ||
|
BIOLASE
BIOL
|
16.7 M | - | -13.19 % | $ 166 K | ||
|
Orthofix Medical
OFIX
|
566 M | $ 11.9 | 0.25 % | $ 471 M | ||
|
AdaptHealth Corp.
AHCO
|
89.3 M | $ 11.04 | 6.41 % | $ 1.49 B | ||
|
Myomo
MYO
|
26.9 M | $ 0.72 | 2.1 % | $ 30.1 M | ||
|
IRadimed Corporation
IRMD
|
64.3 M | $ 99.94 | 0.75 % | $ 1.27 B | ||
|
Nano-X Imaging Ltd.
NNOX
|
-10.6 M | $ 2.36 | -3.28 % | $ 138 M | ||
|
Invacare Corporation
IVC
|
48.3 M | - | - | $ 24.7 M | ||
|
EDAP TMS S.A.
EDAP
|
26.6 M | $ 3.85 | 3.08 % | $ 144 M | ||
|
OrthoPediatrics Corp.
KIDS
|
173 M | $ 16.26 | -1.28 % | $ 381 M | ||
|
Penumbra
PEN
|
942 M | $ 335.06 | -0.15 % | $ 13 B | ||
|
Outset Medical
OM
|
46.8 M | $ 3.51 | -3.04 % | $ 53.4 K | ||
|
Inspire Medical Systems
INSP
|
779 M | $ 51.85 | -0.69 % | $ 1.52 B | ||
|
Insulet Corporation
PODD
|
1.94 B | $ 225.55 | -0.68 % | $ 15.9 B | ||
|
Profound Medical Corp.
PROF
|
4.38 M | $ 5.16 | -4.44 % | $ 180 M | ||
|
Pulmonx Corporation
LUNG
|
67.1 M | $ 1.38 | -1.08 % | $ 56.1 M | ||
|
Quanterix Corporation
QTRX
|
65 M | $ 3.75 | -4.82 % | $ 160 M | ||
|
Cutera
CUTR
|
-12.7 M | - | -10.19 % | $ 1.99 M | ||
|
Dynatronics Corporation
DYNT
|
6.01 M | - | 14.99 % | $ 929 K | ||
|
InspireMD
NSPR
|
2.65 M | $ 1.79 | 3.47 % | $ 115 M |